Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Huntsville, AL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Huntsville, AL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Casa Grande, AZ
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Casa Grande, AZ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Scottsdale, AZ
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Scottsdale, AZ
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Tucson, AZ
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Modesto, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Modesto, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Newport Beach, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Oceanside, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Orange, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Palo Alto, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Poway, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Poway, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Roseville, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
San Diego, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
San Jose, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
San Marcos, CA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
San Marcos, CA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Aurora, CO
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Bridgeport, CT
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Boynton Beach, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Boynton Beach, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Hollywood, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Hollywood, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Largo, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Largo, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Miami, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Miami, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Naples, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Naples, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Orlando, FL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Atlanta, GA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Idaho Falls, ID
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Meridian, ID
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Des Moines, IA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Topeka, KA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Baltimore, MD
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chevy Chase, MD
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Boston, MA
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Chesterfield, MI
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Wyoming, MI
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Wyoming, MI
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Rochester, MN
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Jackson, MS
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Kansas City, MO
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Mexico, MO
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Mexico, MO
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Marlton, NJ
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Marlton, NJ
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Great Neck, NY
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
New York, NY
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated:  8/20/2014
Clinical Research Facility
mi
from
Poughkeepsie, NY
Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of the Efficacy and Safety of ALV003 Treatment in Symptomatic Celiac Disease Patients Maintained on a Gluten-Free Diet
Status: Enrolling
Updated: 8/20/2014
Clinical Research Facility
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials